The Fort Worth Press - Medical Care Technologies (OTC PINK:MDCE) Discusses AI Vision Behind MDCE Melanoma Scan Imaging Platform

USD -
AED 3.672501
AFN 64.000316
ALL 80.660025
AMD 364.155001
ANG 1.790365
AOA 918.00005
ARS 1530.4907
AUD 1.426157
AWG 1.8
AZN 1.699559
BAM 1.716593
BBD 2.014833
BDT 123.096502
BGN 1.683441
BHD 0.377145
BIF 3013.033747
BMD 1
BND 1.278097
BOB 12.259622
BRL 5.189496
BSD 1.000307
BTN 95.794093
BWP 13.621802
BYN 3.022425
BYR 19600
BZD 2.011937
CAD 1.415625
CDF 2340.000238
CHF 0.829825
CLF 0.024352
CLP 961.550243
CNY 6.71325
CNH 6.72586
COP 3304.75
CRC 454.820731
CUC 1
CUP 24.008426
CVE 96.778865
CZK 21.413299
DJF 178.136657
DKK 6.56796
DOP 59.49006
DZD 134.160706
EGP 51.841971
ERN 15
ETB 162.282003
EUR 0.87862
FJD 2.24725
FKP 0.754924
GBP 0.755725
GEL 2.61497
GGP 0.754924
GHS 11.618906
GIP 0.754924
GMD 73.501353
GNF 8797.998859
GTQ 7.639444
GYD 209.30355
HKD 7.84415
HNL 26.849519
HRK 6.620503
HTG 130.916751
HUF 320.970299
IDR 17957
ILS 3.04806
IMP 0.754924
INR 95.78855
IQD 1310.484048
IRR 1374575.000352
ISK 120.370439
JEP 0.754924
JMD 158.265678
JOD 0.708979
JPY 157.6265
KES 129.709897
KGS 87.448194
KHR 4068.10901
KMF 433.000272
KPW 900.000318
KRW 1358.430299
KWD 0.30864
KYD 0.833633
KZT 443.156186
LAK 22438.232325
LBP 89581.428007
LKR 330.293588
LRD 172.063018
LSL 16.32106
LTL 2.95274
LVL 0.60489
LYD 6.395752
MAD 9.599596
MDL 17.756616
MGA 4416.553298
MKD 54.043972
MMK 2099.36214
MNT 3596.164164
MOP 8.082152
MRU 40.243999
MUR 47.789782
MVR 15.45022
MWK 1734.585509
MXN 17.738565
MYR 4.075979
MZN 63.910094
NAD 16.32106
NGN 1327.720263
NIO 36.810462
NOK 9.51841
NPR 153.270725
NZD 1.769295
OMR 0.385571
PAB 1.000307
PEN 3.395971
PGK 4.456927
PHP 62.379014
PKR 277.197262
PLN 3.84189
PYG 5896.344407
QAR 3.646377
RON 4.633902
RSD 103.085092
RUB 84.429704
RWF 1478.474569
SAR 3.755913
SBD 8.000512
SCR 13.862985
SDG 601.507172
SEK 9.936675
SGD 1.278745
SHP 0.755002
SLE 24.649813
SLL 20969.491881
SOS 571.729495
SRD 37.6675
STD 20697.981008
STN 21.503489
SVC 8.753236
SYP 13002.000254
SZL 16.317198
THB 33.45013
TJS 9.228244
TMT 3.51
TND 2.961425
TOP 2.40776
TRY 48.982202
TTD 6.803879
TWD 31.793986
TZS 2644.949629
UAH 44.794751
UGX 3918.023434
UYU 40.075482
UZS 11839.206565
VES 852.43145
VND 25976
VUV 118.388248
WST 2.745723
XAF 576.337115
XAG 0.015704
XAU 0.000235040274
XCD 2.70255
XCG 1.80287
XDR 0.707052
XOF 576.337115
XPF 104.673717
YER 236.649761
ZAR 16.343745
ZMK 9001.19134
ZMW 19.513758
ZWL 321.999592
SSP 5712.5919
MXV 2.010167
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Medical Care Technologies (OTC PINK:MDCE) Discusses AI Vision Behind MDCE Melanoma Scan Imaging Platform
Medical Care Technologies (OTC PINK:MDCE) Discusses AI Vision Behind MDCE Melanoma Scan Imaging Platform

Medical Care Technologies (OTC PINK:MDCE) Discusses AI Vision Behind MDCE Melanoma Scan Imaging Platform

Company outlines long-term strategy surrounding AI-assisted imaging technologies and pre-screening wellness applications

Text size:

MESA, AZ / ACCESS Newswire / June 4, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE), ("MDCE" or the "Company"), a technology company focused on AI-powered consumer applications and imaging technologies, today provided additional insight into the long-term strategic vision supporting the development of its MDCE Melanoma Scan Beta platform and broader AI imaging initiatives.

The Company stated that the MDCE Melanoma Scan Beta platform represents an important component of a larger technology strategy centered on AI-assisted imaging, image management systems, and future image analysis infrastructure. While the current platform remains in beta-stage development, Medical Care Technologies views the project as part of a broader effort to explore how artificial intelligence may be utilized to support future wellness-oriented imaging applications.

Medical Care Technologies believes advancements in artificial intelligence, computer vision technologies, image processing systems, and scalable software infrastructure are creating new opportunities for the development of intelligent imaging platforms capable of supporting a wide range of future use cases.

"Our vision extends beyond a single application," stated Marshall Perkins, Chief Executive Officer of Medical Care Technologies. "We are evaluating how AI-assisted imaging technologies, image analysis frameworks, and scalable software infrastructure may be applied across multiple future technology initiatives. The MDCE Melanoma Scan Beta platform serves as an important foundation within that broader strategy."

The Company noted that ongoing development activities are helping establish internal expertise and technical infrastructure related to imaging workflows, image management systems, software architecture, and future AI-assisted analytical capabilities.

Medical Care Technologies further stated that it believes imaging technologies may represent an important long-term category within preventative wellness, consumer health applications, and future digital monitoring platforms. As a result, the Company intends to continue evaluating opportunities involving AI-assisted imaging systems and related technology initiatives as part of its broader innovation strategy.

The Company emphasized that its current efforts remain focused on development, testing, refinement, and evaluation activities associated with the MDCE Melanoma Scan Beta platform. Future technology initiatives, expansion opportunities, and potential applications remain subject to ongoing research, development progress, resource availability, regulatory considerations, and market conditions.

"Our objective is to build a technology foundation that supports innovation across multiple future opportunities," added Perkins. "We believe the convergence of artificial intelligence, imaging technologies, and scalable software platforms may create meaningful opportunities for continued development and exploration."

Medical Care Technologies expects to continue providing shareholders with updates regarding platform development activities, AI imaging initiatives, testing programs, infrastructure expansion efforts, and broader technology strategy milestones as they occur.

The MDCE Melanoma Scan Beta platform remains in beta-stage development and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. The platform has not been reviewed or cleared by the U.S. Food and Drug Administration.

About Medical Care Technologies Inc.

Medical Care Technologies Inc. is a technology company focused on AI-powered consumer applications, imaging technologies, wellness platforms, authentication technologies, and digital innovation initiatives. The Company continues to evaluate opportunities involving artificial intelligence, imaging systems, software development, and emerging technology applications.

Investor / Media Contact:
Medical Care Technologies Inc.
1910 S Stapley Drive
Suite 221
Mesa, AZ 85204
+1 480-645-0750
[email protected]

X: https://x.com/medicalcaretech
Website: https://medicalcaretechnologies.com/

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. These statements involve risks and uncertainties that could cause actual results to differ materially from those projected. Forward-looking statements include, but are not limited to, statements regarding future development initiatives, AI imaging technologies, technology strategy, testing plans, commercialization opportunities, platform expansion efforts, and future growth objectives. The Company undertakes no obligation to publicly update forward-looking statements except as required by applicable law.

SOURCE: Medical Care Technologies Inc.



View the original press release on ACCESS Newswire

A.Nunez--TFWP